Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 27,094 shares at $10.15 ($275K) on 2019-01-08, disclosed to the SEC on 2019-01-11.
Seasonal sale ($275k) by Chief Operating Officer — this insider has traded STML in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.15 | 13,547 | $138K | 50.0% |
| 2 | $10.15 | 13,547 | $138K | 50.0% |
| Total | $10.15 avg | 27,094 | $275K | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $148K | — | Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |